Concerta Guidance: Sub x Form inter­action vari­ance test [Regulatives / Guidelines]

posted by jag009  – NJ, 2014-12-05 21:57 (4220 d 03:59 ago) – Posting: # 13991
Views: 19,292

Hi everyone,

Question regarding the sub*Form interaction variance test required for Concerta draft guidance...

"Subject-by-formulation interaction variance, σ2D2I-0.5*(σ2wt + σ2wr)

In Step 4..."As per APPENDIX A in the FDA 2001 bioequivalence guidance, the recommended allowance for σ2D is 0.03."


They are referring to σ2D value being no greater than 0.03 right? Can the number be negative, i.e, -0.06?

Thanks
John
Thread locked

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
138 visitors (0 registered, 138 guests [including 25 identified bots]).
Forum time: 02:57 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5